What Lilly is doing with its advertising campaign is taking the highest dose of its medicine and comparing it to a lower dose of the Novo medicine and then it is deceiving the people who see these campaigns into believing that the Lilly drug is greatly superior to the Novo drug. So it's it's not terribly complicated. They're using an old outdated study that that is a head-to-head study which is no longer current.And if they were using current data, it paints a very different picture. What we will show first ...

Ozempic drugmaker Novo Nordisk sued rival GLP-1 manufacturer Eli Lilly in federal court Tuesday, accusing the company of using “intentionally selected outdated studies” to curate allegedly misleading ad campaigns that exaggerate the efficacy of Lilly’s products.Read more: https://t.co/lQkC3tU6LNPhoto: Michael Siluk/UCG/Universal Images Group via Getty Images ...

Joining us now is John Coleman, group general counsel at Novo Nordisk. John. Thank you very much for joining us this morning.And look before the court. You have to present this argument, not necessarily that what they presented is false, but it's factually true but misleading. That's a bit difficult to do.So what sort of evidence, surveys and otherwise are you bringing to the court showing that consumers were actually misled by this ad and Novo suffered as a result of it. Good morning, and thank you very mu ...

Time for Kramer's mad dash ahead of the bill. >> Yeah, I mean I I I want to just try to I was incredibly bullish about Lily as I have been for a lot and I'm sticking by it. I believe that this lawsuit by Novo is not a big deal.Uh if they think their product is really better than Lily's my suggestion as someone who owns it for the travel trust is prove it. Go do a headto-head with Lily. Um because that's what they did.I'm looking at New England Journal of Medicine article that came out not that long ago um w ...

I'm Jessica Edinger, CNBC. Wall Street is higher out of the gate. Investors shrugging off a heating up US war with Iran.The Dow is up 94 points. It's being lit higher by shares of 3M. They're up almost 8% this morning on strong quarterly results.The S&P 500 index up 31 points. The Nasdaq's up 226 points. That's 9/10en of a percent.Chipmaker shares higher this morning. Micron up 8 and a half% out of the gate. Intel up 6%, AMD up 5%, Taiwan semis up 4% this morning.Last night marked the 10th straight day of U ...

Novo Nordisk said it’s suing Eli Lilly in US federal court, claiming that Lilly’s advertising for its blockbuster obesity shot Zepbound and diabetes injection Mounjaro is misleading https://t.co/Ap4Zou0thf ...

The lawsuit, filed in federal court Tuesday, accuses Eli Lilly of using outdated data in advertising campaigns.https://t.co/4zqVIWP3wS https://t.co/zQXTEdDOyy ...